Ajooni Biotech (NSE:AJOONI) Other Current Receivables: ₹2 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:AJOONI Ajooni Biotech Ltd NSE:AJOONI
62 GF Score
Price ₹3.47
GF Value ₹6.16
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Ajooni Biotech Other Current Receivables?

Ajooni Biotech NSE:AJOONI -0.86% 62 Other Current Receivables is ₹2 Mil as of Mar. 2026. GuruFocus rates NSE:AJOONI with a GF Score™ of 62/100 and a GF Value™ of ₹6.16 (Possible Value Trap). The stock has 4 warning signs investors should review.

Ajooni Biotech's Other Current Receivables for the quarter that ended in Mar. 2026 was ₹2 Mil.

Ajooni Biotech's quarterly Other Current Receivables declined from Dec. 2024 (₹145.86 Mil) to Mar. 2025 (₹1.87 Mil) but then stayed the same from Mar. 2025 (₹1.87 Mil) to Mar. 2026 (₹1.82 Mil).

Ajooni Biotech's annual Other Current Receivables increased from Mar. 2024 (₹0.59 Mil) to Mar. 2025 (₹1.87 Mil) but then declined from Mar. 2025 (₹1.87 Mil) to Mar. 2026 (₹1.82 Mil).

Ajooni Biotech Other Current Receivables Related Terms

Ajooni Biotech Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Ajooni Biotech's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ajooni Biotech Other Current Receivables Chart

Ajooni Biotech Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 21.47 0.61 0.59 1.87 1.82

Ajooni Biotech Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Mar26
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 163.24 138.69 145.86 1.87 1.82
NSE:AJOONI
62GF Score
Ajooni Biotech Ltd NSE:AJOONI
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ajooni Biotech Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of ₹2 Mil mean?
Ajooni Biotech (NSE:AJOONI) has a Other Current Receivables of ₹2 Mil as of Mar. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Ajooni Biotech and its competitors.
Is Ajooni Biotech's Other Current Receivables too high?
Ajooni Biotech's current Other Current Receivables is ₹2 Mil. Overall, Ajooni Biotech has a GF Score™ of 62/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Ajooni Biotech's Other Current Receivables compare to KHC and GIS?
Ajooni Biotech's Other Current Receivables of ₹2 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Consumer Packaged Goods company?
A good Other Current Receivables depends on the Consumer Packaged Goods industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Ajooni Biotech and its competitors. Ajooni Biotech's current Other Current Receivables is ₹2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ajooni Biotech stock overvalued right now?
Based on GuruFocus' analysis, Ajooni Biotech (NSE:AJOONI) is currently considered Possible Value Trap. The stock's GF Value™ is ₹6.16, compared to a current price of ₹3.47 — trading 43.7% below its estimated fair value. The current Other Current Receivables is ₹2 Mil. Ajooni Biotech's overall GF Score™ is 62/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Ajooni Biotech (NSE:AJOONI), the current Other Current Receivables is ₹2 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ajooni Biotech (NSE:AJOONI) Overvalued in 2026?

Based on GuruFocus' analysis, Ajooni Biotech stock appears to be undervalued. The current stock price of ₹3.47 is trading 43.7% below its estimated GF Value™ of ₹6.16. GuruFocus considers Ajooni Biotech to be Possible Value Trap.

Key valuation signals for NSE:AJOONI:

  • Other Current Receivables: ₹2 Mil
  • GF Value™: ₹6.16 vs. price of ₹3.47 (43.7% below fair value)
  • GF Score™: 62/100 with 4 warning signs

No single metric tells the full story. See the NSE:AJOONI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ajooni Biotech Business Description

Address House No. 1769, Phase 3B2, Mohali, PB, IND, 160055
Ajooni Biotech Ltd is engaged in providing animal health care solutions dedicated to improving the productivity of Dairy farmers and sustainably increasing livestock yields. The company's products of cattle feed include Gold Pashu Aahar, Buff Plus, 3 Star, 4 Star, Calf Starter, & Transition Plus, and its feed supplements include Calvit, Batisa, Liv, Min, and other products. It derives majority portion of the revenue from the manufacturing of cattle feed. The company operates only in India.
62GF Score

Get the complete analysis for NSE:AJOONI

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹3.47
Price
₹6.16
GF Value